Knowledge is power. Are you facing a new diagnosis or recurrence of Liver Cancer? The GI Connection Liver Cancer Information Center has current, evidence-based information for you. Get the facts about the prevention, treatment, and living with Liver Cancer. Stay up to date with news, tips, and features designed to keep you informed about the most recent developments and advances. Learn more about Liver Cancer.
You are not alone—The GI Connection Community is the leading Social Media Application for individuals seeking information, inspiration, and support. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs. Login or register here.
November 13, 2018
Keytruda Immunotherapy for Treatment of Liver Cancer
According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an active treatment […]
Tags: Liver Cancer, News Tips and Features, News Tips and Features Other
August 20, 2018
FDA Approves Lenvatinib for Treatment of Advanced Hepatocellular Cancer
The U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA® (lenvatinib) for the first-line treatment of patients with […]
Tags: Liver Cancer, News Tips and Features, News Tips and Features Other
July 12, 2018
Cyramza Improves Survival in Poor-Prognosis Liver Cancer
Andrew X. Zhu, MD, PhD, director of Liver Cancer Research at Massachusetts General Hospital presented new data at the 2018 […]
Tags: cyramza, hepatocellular cancer treatment, Liver Cancer, News Tips and Features, News Tips and Features Other
February 20, 2018
Cabometyx™ May Be ‘New Treatment Option’ for Liver Cancer
CancerConnect News: Treatment with Cabometyx (cabozantinib) significantly improved outcomes in patients with advanced hepatocellular carcinoma (HCC), leading researchers to suggest […]
Tags: Cabometyx, cabozantinib, hepatocellular cancer, Liver Cancer, News Tips and Features, News Tips and Features Other
February 15, 2018
Keytruda Immunotherapy Appears Active for Treatment of Liver Cancer
CancerConnect News: According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an […]
Tags: checkpoint inhibitor, hepatocellular cancer, immunotherapy, keytruda, Liver Cancer, News Tips and Features, News Tips and Features Other, pembrolizumab, Precision Cancer Medicine
May 18, 2017
Opdivo Precision Cancer Medicine Improves Outcomes in Advanced Liver Cancer
Results from the CheckMate 040 clinical trial have been recently reported and found that Opdivo (nivolumab), an immuno-oncology drug which […]
Tags: CheckMate 040 nivolumab, immuno-oncology, Liver Cancer, News Tips and Features, News Tips and Features Other, Opdivo, PD-1, Precision Cancer Medicine
May 8, 2017
First New Drug for Liver Cancer in a Decade: Stivarga
The US Food and Drug Administration (FDA) has expanded the indication for Stivarga (regorafenib) to now include treatment for patients […]
Tags: immunotherapy, Liver Cancer, News Tips and Features, News Tips and Features Other, regorafenib, Stivarga
 |
 |
 |
